VIRGINIA RETIREMENT SYSTEMS ET Al Buys New Position in Encompass Health Corporation $EHC

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Encompass Health Corporation (NYSE:EHC) during the 2nd quarter, HoldingsChannel reports. The firm bought 10,631 shares of the company’s stock, valued at approximately $1,304,000.

Several other hedge funds have also modified their holdings of EHC. OneDigital Investment Advisors LLC acquired a new stake in Encompass Health during the 1st quarter valued at approximately $263,000. GAMMA Investing LLC grew its stake in Encompass Health by 21.5% during the 1st quarter. GAMMA Investing LLC now owns 2,366 shares of the company’s stock valued at $240,000 after purchasing an additional 419 shares in the last quarter. Sequoia Financial Advisors LLC grew its stake in Encompass Health by 6.7% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company’s stock valued at $276,000 after purchasing an additional 172 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its stake in Encompass Health by 30.1% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company’s stock valued at $972,000 after purchasing an additional 2,218 shares in the last quarter. Finally, Intech Investment Management LLC grew its stake in Encompass Health by 21.8% during the 1st quarter. Intech Investment Management LLC now owns 21,329 shares of the company’s stock valued at $2,160,000 after purchasing an additional 3,815 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 2.00% of the stock is owned by insiders.

Analysts Set New Price Targets

EHC has been the subject of a number of recent analyst reports. Truist Financial raised their price objective on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. UBS Group lifted their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. KeyCorp lifted their target price on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. Finally, Bank of America lifted their target price on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. One analyst has rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $139.86.

Encompass Health Stock Up 1.1%

Shares of Encompass Health stock opened at $126.22 on Thursday. The business’s fifty day moving average price is $123.98 and its two-hundred day moving average price is $117.66. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The company has a market capitalization of $12.71 billion, a P/E ratio of 24.70, a PEG ratio of 2.18 and a beta of 0.93. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.86.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current year.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.